ISAP Researchers' Profiles

David Farabee, Ph.D.

David Farabee, Ph.D., is Professor-in-Residence of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles and a Principal Investigator at the Integrated Substance Abuse Programs (ISAP). Prior to this he served as lead analyst for criminal justice research at the Texas Commission on Alcohol and Drug Abuse (1992-1995), and as Assistant Professor of Psychiatry and Research Scientist at the University of Kentucky Center on Drug and Alcohol Research (1995-1997). He is currently Principal Investigator of a clinical trial comparing four types of counseling styles with regard to their ability to promote abstinence for stimulant abusers (funded by the National Institute on Drug Abuse), and Co-Principal Investigator of the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) (also funded by NIDA). He is also Principal Investigator on two projects funded by the California Department of Corrections and Rehabilitation—one focusing on pre-parole planning; the other on validating the COMPAS risk and needs assessment. From 2002-2005, he served as a member of the U.S. Health and Human Services Advisory Committee on HIV and STD Prevention for the Centers for Disease Control.

Dr. Farabee has published in the areas of substance abuse, adult and juvenile crime, HIV/AIDS, and offender treatment, was co-editor of the books Treatment of Drug Offenders (2002; New York: Springer) and Treating Addicted Offenders: A Continuum of Effective Practices, Volumes I and II (2004, 2007; New York: Civic Research Institute), author of, Rethinking Rehabilitation: Why Can’t We Reform Our Criminals? (2005; Washington, D.C.: AEI Press), and is co-editor of the Offender Programs Report.

Education and Training

• University of Texas, Austin, B.A., Psychology, 1985
• Texas A&M University, Commerce, M.S., Psychology, 1988
• Texas Christian University, Ft. Worth, Ph.D., Experimental Psych., 1992

Specialties

• Drugs & Crime
• Program Evaluation
• Offender Interventions

Contact Info

UCLA Integrated Substance Abuse Programs
11075 Santa Monica Blvd., Suite 100
Los Angeles, CA 90025
dfarabee@ucla.edu

Selected Publications

1993 Farabee, D., Nelson, R., Spence, R. Psychosocial profiles of criminal justice- and non-criminal justice-referred clients in treatment. Criminal Justice and Behavior, 20, 336-346.

1995 Farabee, D., Simpson, D.D., Dansereau, D., & Knight, K.  Cognitive inductions into treatment among drug users on probation. Journal of Drug   Issues, 25, 669-682.

1996 Farabee, D., & Fredlund, E.V.  Self-reported drug use among recently admitted jail inmates: Estimating prevalence and treatment needs. Substance Use and Misuse, 31, 423-435.

1998 Farabee, D.,  Leukefeld, C.G., & Hays, L.R.  Accessing drug abuse treatment: Perceptions of  out-of-treatment injectors. Journal of Drug Issues, 28(2), 381-394.

1998 Farabee, D., Prendergast, M.L., & Anglin, M.D. The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62, 3-10.

1999 Farabee, D., Prendergast, M.L., Cartier, J., Wexler, W., Knight., K., &  Anglin, M.D. Barriers to implementing effective correctional treatment programs. The Prison Journal, 79(2), 150-162.

1999 Farabee, D., & Leukefeld, C.G. Opportunities for AIDS prevention in a rural state in criminal justice and substance abuse treatment settings.Substance Use and Misuse, 34 (4&5), 617-632.

2001 Farabee, D., Joshi, V., & Anglin, M.D. Addiction careers and criminal specialization. Crime & Delinquency, 47(2), 196-220.

2001 Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of substance abuse treatment on adolescent criminality. Journal of Adolescent Research, 16(6), 679-696.

2002 Farabee, D. Editor of special issue: Making people change: The effectiveness of coerced psychological treatment. Criminal Justice and Behavior, 29(1).

2002 Farabee, D. Re-examining Martinson’s critique: A cautionary note for evaluators. Crime & Delinquency, 48(1), 189-192. 

2002 Farabee, D. Addicted to treatment: Ideology is trumping science in our quest to rehabilitate offenders. Forbes, December 23. p.60.

2002 Farabee, D., Prendergast, M.L., & Cartier, J.Alcohol, the “un-drug.” Psychiatric Services, 53 (11), 1375-1376.

2002 Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs, 34(3), 295-300.

2002 Farabee, D., Rawson, R.A.,  & McCann, M. Adoption of drug      avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350.

2002 Farabee, D., Shen, H., & Sanchez, S. Perceived coercion and treatment need among  mentally ill parolees. Criminal Justice and Behavior, 29(1), 76-86.

2002 Rawson, R.A, Huber, A., McCann, M., Shoptaw, S., Farabee, D., Reiber, C., & Ling, W. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry, 59, 817-824.

2003 Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder in cognitive behavioral and contingency management interventions. Journal of Consulting and Clinical Psychology, 71(2), 320-329.

2004 Farabee, D., Hser, Y.H., Anglin, M.D., & Huang, D. Recidivism among an early cohort of California’s Proposition 36 offenders. Criminology & Public Policy, 3(4), 501-522.

2004 Farabee, D., Shen, H., & Sanchez, S.  Program-level predictors of antipsychotic medication adherence among parolees.  International Journal of Offender Therapy and Comparative Criminology, 48(5), 561-571.

2004 Farabee, D., & Shen, H.Antipsychotic medication adherence, cocaine use, and recidivism among a parolee sample.Behavioral Sciences and the Law, 22, 467-476.

2004 Prendergast, M.L., Campos, M., Farabee, D., Evans, W., & Martinez, J. Reducing substance use in prison: The California Department of  Corrections Drug Reduction Strategy Project. The Prison Journal, 84 (2), 265-280.

2006 Cartier, J., Farabee, D., & Prendergast, M.L. Methamphetamine use, violence, and recidivism among California parolees. Journal of Interpersonal Violence, 21, 435-445.

2006 Farabee, D. An evaluation of California’s Mental Health Services Continumm Program for parolees. Corrections Today, 68(7), 38-41.

2006 Farabee, D. Why the expansion of offender programs is premature. Journal of Community Corrections, 16(1), 9-10.

2006 Farabee, D. Reinventing criminal justice. Washington Post, February 11, . p A19.

2006 Farabee, D. Naltrexone as negative reinforcement: Comments on "A behavioral analysis of coercion in substance abuse treatment." Journal of Substance Abuse Treatment, 31(2), 141-142.

2007 Farabee, D. For the Second Chance Act of 2007, great strides will come in small steps. Federal Sentencing Reporter, 20 (2), 136-137.

2007 Farabee, D., Knight, K., Garner, B., & Calhoun, S. The Inmate Pre-Release Assessment (IPASS) for re-entry planning. Criminal Justice & Behavior, 34(9), 1188-1197.

In press Peng E.Y., Yeh C.Y., Lyu S.Y., Morisky D.E., Chen Y.M., Lee M.B., Farabee D., & Malow R. Prevalence and correlates of lifetime suicidal ideation among HIV-infected male inmates in Taiwan. AIDS Care.

In press Peng, E.Y., Lee, M., Morisky, D.E., Yeh, C.Y., Farabee, D., Lan, Y.C., Chen, Y.M.A., Lyu, S.Y. Psychiatric morbidity in HIV-infected male prisoners. Journal of the Formosan Medical Association.

Books

2002 Leukefeld, C.G., Tims, D., &  Farabee, D. (Eds.) Treatment of Drug Offenders: Policies and Issues.New York: Springer.

2004 Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A Continuum of Opportunities. New York: Civic Research Institute.

2005 Farabee, D. Rethinking Rehabilitation: Why Can’t We Reform Our Criminals? Washington, DC: American Enterprise Institute.

2007 Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A Continuum of Opportunities, Vol II. New York: Civic Research Institute.

Last updated - 11/04/2011

Top of Page